Previous Article | Next Article 
Journal of Virology, December 1998, p. 10171-10179, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Rapid Selection in Modified BHK-21 Cells of a Foot-and-Mouth
Disease Virus Variant Showing Alterations in Cell Tropism
Cristina
Escarmís,1
Elisa C.
Carrillo,2
Marcela
Ferrer,3
Juan F. García
Arriaza,1
Nora
Lopez,3
Cecilia
Tami,2
Nuria
Verdaguer,4
Esteban
Domingo,1,* and
Maria T.
Franze-Fernández3,*
Centro de Biología Molecular "Severo Ochoa"
(CSIC-UAM), Universidad Autónoma de Madrid, 28049 Madrid,
Spain1;
Instituto de
Biotecnología, Centro de Investigación en Ciencias
Veterinarias, INTA 1708 Morón, Buenos
Aires,2 and
Centro de
Virología Animal (CONICET), Serrano 669, 1414 Buenos
Aires,3 Argentina; and
Centre de
Investigació i Desenvolupament (CSIC), Jordi Girona 6, 08028 Barcelona, Spain4
Received 26 June 1998/Accepted 9 September 1998
 |
ABSTRACT |
With persistent foot-and-mouth disease virus (FMDV) in BHK-21
cells, there is coevolution of the cells and the resident virus; the
virulence of the virus for the parental BHK-21 cells is gradually increased, and the cells become partially resistant to FMDV. Here we
report that variants of FMDV C3Arg/85 were selected in a
single infection of partially resistant BHK-21 cells (termed BHK-Rb
cells). Indirect immunofluorescence showed that the BHK-Rb cell
population was heterogeneous with regard to susceptibility to
C3Arg/85 infection. Infection of BHK-Rb cells with
C3Arg/85 resulted in an early phase of partial
cytopathology which was followed at 6 to 10 days postinfection by the
shedding of mutant FMDVs, termed C3-Rb. The selected
C3-Rb variants showed increased virulence for BHK-21 cells,
were able to overcome the resistance of modified BHK-21 cells to
infection, and had acquired the ability to bind heparin and to infect
wild-type Chinese hamster ovary (CHO) cells. A comparison of the
genomic sequences of the parental and modified viruses revealed only
two amino acid differences, located at the surface of the particle, at
the fivefold axis of the viral capsid (Asp-9
Ala in VP3 and either
Gly-110
Arg or His-108
Arg in VP1). The same phenotypic and
genotypic modifications occurred in a highly reproducible manner; they
were seen in a number of independent infections of BHK-Rb cells with
viral preparation C3Arg/85 or with clones derived from it.
Neither amino acid substitutions in other structural or nonstructural
proteins nor nucleotide substitutions in regulatory regions were found.
These results prove that infection of partially permissive cells can
promote the rapid selection of virus variants that show alterations in
cell tropism and are highly virulent for the same cells.
 |
INTRODUCTION |
Foot-and-mouth disease virus (FMDV)
is an important animal pathogen of the genus aphthovirus of the
Picornaviridae family (48). FMDV usually causes
an acute, systemic infection in cloven-hooved animals and cytolytic
infections in cell culture. However, FMDV can also establish persistent
infections in ruminants (3, 29, 36, 50, 53, 55, 56) and in
cell cultures (9, 12, 21). Persistence in cell cultures was
established by infecting cloned BHK-21 cells (a population derived from
a single cell) with an FMDV of serotype C (clone C-S8c1) that was
plaque purified three times (9). The carrier cultures were
obtained by growing the cells that survived the cytolytic infection (at
a frequency of about 10
3) (9, 37). At the
critical step of initiation of persistence, the prevailing event
ensuring cell survival and viral replication was the rapid variation of
the cells, which became partially resistant to FMDV (37).
The FMDV then became increasingly virulent for BHK-21 cells (12,
37). In a virulence assay that measures the minimal amount of
virus needed to kill 104 BHK-21 cells in 24 h under
standard conditions, the virus shed by persistently infected cells at
passage 100, termed R100, was 1,000-fold more virulent than the
parental C-S8c1 (51).
The evolution of BHK-21 cells during FMDV persistence could be
characterized because treatment of the carrier cells with ribavirin [(1-
-D-ribofuranosyl)-1-H-1,2,4-triazole-3-carboxamide]
eliminated the virus from the cells (8). Cured cells, in
which virus could not be detected by reverse transcription (RT)-PCR
(37), were partially resistant to infection by several
isolates of FMDV of serotypes C, O, and A but produced normal
yields of other RNA viruses, such as vesicular stomatitis virus,
encephalomyocarditis virus, and Semliki Forest virus (9, 12,
37). The degree of resistance to FMDV of carrier cells increased
with the passage number of the persistently infected culture (11,
12). The evolving cell populations were heterogeneous with regard
to susceptibility to FMDV, as revealed by the analysis of 248 stable
cell clones isolated from carrier cells at passages 17, 19, 62, and 74 (11). At least six distinct cell phenotypes were identified,
the most-resistant clones producing 104 times less FMDV
C-S8c1 progeny than the standard BHK-21 cells (11).
In the present study we have examined the ability of cloned FMDV
C3Arg/85 to overcome the resistance of modified
BHK-21 cells. C3Arg/85 is a standard South American
type C FMDV of which several isolates and cloned preparations have been
previously characterized genetically (39, 43) and
antigenically (38, 54). The results show a surprising
adaptability of FMDV to overcome the cellular barrier in a single
infection of a monolayer of modified BHK-21 cells. The selected
progeny virus displayed increased virulence for BHK-21 cells and
modified BHK-21 cells along with a number of additional phenotypic
alterations. Two amino acid substitutions located at the surface of the
viral capsid are associated with the dramatic phenotypic changes.
 |
MATERIALS AND METHODS |
Cells, viruses, and infections.
The origin of BHK-21
cells and the procedures used for infection of BHK-21 and Chinese
hamster ovary (CHO) cell monolayers with FMDV in liquid and in
semisolid media have been previously described (2, 12, 16,
52). BHK-Rb cells derive from a subline of BHK-21 cells
persistently infected with FMDV C-S8c1. They were cured of FMDV by
ribavirin treatment (8) at cell passage 70 after the
initiation of persistence. BHK-Rb cells correspond to the
population termed C1BHK-Rc1-p70 Rbv in de la Torre et
al. (11). BHK-Rb cells were used between passages 9 and
15 after curing with ribavirin. Cell clone BHK-R74-A4 was obtained
by growth of a single cell from passage 74 of the persistently infected cell population C1-BHK-Rcip74, as described by de la
Torre et al. (11). Cell populations BHK-Rb and
BHK-R74-A4 were routinely monitored by RT-PCR amplification with
primers corresponding to different regions of FMDV RNA, with negative
results. Wild-type CHO cells and the two glycosaminoglycan-deficient
CHO mutants pgs D-677 and pgs A-745 were kindly provided by J. D. Esko (27, 35).
The FMDV C3Arg/85 isolate used was passaged twice in
BHK-21 cells and plaque purified in BHK-21 cells, and then the
cloned virus was passaged three times in BHK-21 cells to produce
the viral preparation (working stock) for the experiments described here.
Generation of FMDV C3-Rb.
Subconfluent
BHK-Rb cell monolayers were infected either with
C3Arg/85 or with plaque-purified viral clones derived from
the C3Arg/85 working stock and incubated with Dulbecco
modified Eagle medium (DMEM) containing 2% fetal calf serum until the
cell monolayer became partially lysed at 2 to 3 days postinfection. At
this time, the medium was replaced by DMEM containing 10% fetal calf
serum, and the incubation was continued, with the medium changed every 24 h. Virus rescued from the supernatants at 8 to 10 days
postinfection was generically designated C3-Rb.
Virulence assay.
The virulence of FMDV for BHK-21 cells
and for modified BHK-21 cells is defined as the minimum number of
PFU required to kill a designated number of cells in a given time (both
parameters are indicated for each experiment) under standard infection
conditions (51).
Indirect immunofluorescence assays.
Cells were grown on
coverslips, washed extensively with phosphate-buffered saline, placed
on ice, rinsed, fixed in acetone (10 min at
20°C), air dried, and
stored at
20°C. Immunofluorescence was performed as previously
described (28), with a 1:50 dilution of anti-FMDV
C3 polyclonal antiserum raised in guinea pigs used as the
primary antibody. The secondary antibody was a 1:100 dilution of a
fluorescein-conjugated anti-guinea pig immunoglobulin G (Sigma).
Heparin-Sepharose binding of FMDV.
Heparin-Sepharose CL-6B
and control Sepharose CL-6B beads (ligand density, ~2 mg of porcine
heparin/ml of drained gel; Pharmacia Biotech) were equilibrated with a
combination of DMEM, 25 mM HEPES, and 0.1% fetal calf serum (binding
buffer) and resuspended as a 10% (vol/vol) slurry; 200 µl of the
slurry was mixed with 300 µl of the virus diluted in binding buffer
(105 to 106 PFU). The virus-heparin-Sepharose
and virus-Sepharose mixtures were incubated for 1 h at room
temperature with gentle stirring and centrifuged at 1,000 × g for 2 min. Virus recovered in the supernatants was quantitated
by plaque assay. In all cases, 100% of the input PFU was recovered
from the supernatant of the Sepharose CL-6B control beads, indicating
stability of the virus during the procedure.
Isolation of viral RNA, cDNA synthesis, PCR amplification,
nucleotide sequencing, and determination of the size of the poly(C)
tract.
Viral RNA from the supernatants of infected cultures was
obtained by treatment with proteinase K and sodium dodecyl sulfate, followed by phenol extraction, as previously described (26). To determine the length of the poly(C) tract, the supernatants of
infected cells were treated with 2 µg of DNase per ml and 4.5 µg of
pancreatic RNase per ml in 50 mM Tris (pH 7.5)-10 mM MgCl2 for 50 min at 37°C prior to treatment with proteinase K as described above. Amplification of FMDV RNA fragments by RT-PCR was carried out as
described by Escarmís et al. (26) either with the sets of primers that have been previously described (2, 25, 26, 51) or with those designed for efficient RT-PCR amplification of
the C3Arg/85 genome. The sequences of the oligonucleotide
primers used will be provided upon request. DNA fragments were purified from unincorporated deoxynucleoside triphosphates and primers by
treatment with shrimp alkaline phosphatase and exonuclease I
(Amersham). Nucleotide sequencing was performed on overlapping DNA
fragments with either the thermosequenase kit from Amersham or the
femtomole DNA cycle sequencing kit from Promega (26). A few
sequences were determined with an automatic sequencer (model no.
ABI373). To our knowledge, these results provide the first entire
genomic sequence of an FMDV of subtype C3. To determine the
size of the polyribocytidylate [poly(C)] tract of the FMDV RNA, we
treated about 10 ng with 5 U of RNase T1 in TE (10 mM Tris-HCl [pH 8.0], 1 mM EDTA) in a volume of 5 µl for 30 min at 37°C. Then, 1 µl of a 10× kinase buffer (500 mM Tris-HCl [pH
7.5], 100 mM MgCl2, 100 mM dithiothreitol, 8 U of RNasin),
45 µCi of [
-32P]ATP (150 µCi/µl; 6,000 Ci/mmol),
and 2.5 U of T4 polynucleotide kinase were added, and the mixture
(final volume, 10 µl) was incubated 30 min at 37°C. The size of the
poly(C) tract was determined by electrophoresis in a 6%
polyacrylamide-7 M urea gel, with a nucleotide sequence ladder used as
a size marker (25).
Extraction and quantification of intracellular FMDV RNA.
To
quantify relative amounts of intracellular FMDV RNA, total cellular RNA
was extracted by the procedure of Chomczynski and Sacchi
(7). Aliquots of RNA corresponding to 105,
104, and 103 cells were spotted onto
nitrocellulose filters and hybridized onto a probe covering the entire
P1 region of FMDV C3Arg/85. The probe was labelled with
[32P]phosphate by using the oligolabelling kit
(Pharmacia). Autoradiographs were quantitated by the Fotoanalyst image
analysis system (Fotodyne, Inc.).
Positioning of amino acid replacements on the three-dimensional
structure of FMDV.
The crystallographic coordinates of C-S8c1 (pdb
entry, 1fmd [34]) have been used as a reference to
model the amino acid replacements found in FMDV C3-Rb. The
substituted residues have been modeled with the program TURBO
(47) by placing the side-chain atoms in one of their
standard conformations. The structure has been optimized by removing
the close contacts by using the same program.
Nucleotide sequence accession numbers.
The nucleotide
sequences determined in the present study were deposited in GenBank
under accession no. AJ007347 and AJ007572.
 |
RESULTS |
Rapid evolution of FMDV C3Arg/85 in BHK-Rb
cells.
BHK-Rb cells, obtained by eliminating FMDV from
persistently infected C1-BHK-Rc1p70 cells
(11) (Fig. 1A), were partially resistant to infection by FMDV C3Arg/85. While parental
BHK-21 cells infected with C3Arg/85 at a multiplicity
of infection of 5 to 10 PFU/cell developed a complete cytopathic effect
at 16 to 20 h postinfection, parallel infections in BHK-Rb
cells did not show signs of cytopathology until 2 to 3 days after
infection. At that time, partial cell lysis was observed. Five
independent infections of BHK-Rb cells with either the initial
clonal preparation of C3Arg/85 or three clonal derivatives
of the same preparation (-c1, -c2, and -c3) (Fig. 1B) were carried out.
The 20 to 50% of cells surviving at 2 to 3 days postinfection did not
reach confluence in subsequent days and shed virus that was
increasingly virulent for the host cells. This finding was revealed by
a virulence assay that measures the minimal amount of virus needed to
kill BHK-Rb cells under standard infection conditions
(51) (Table 1). While
104 to 105 PFU of virus shed at 6 to 10 days
postinfection was sufficient to kill the BHK-Rb cells in each of
five independent experiments, a 100-fold-higher amount of the parental
C3Arg/85 either did not affect or only partially killed the
BHK-Rb cells (Table 1). The C3-Rb viruses shed by the
BHK-Rb-infected cells at 8 or 10 days postinfection were termed
C3-RbA, C3-RbB, C3-RbC,
C3-RbD, and C3-RbE (Fig. 1B). In addition to
increased virulence for BHK-Rb cells, all these viruses displayed a
small-plaque phenotype compared with that of the parental virus
in BHK-21 cells and acquired the ability to form plaques on
BHK-Rb cell monolayers. The parental working stock of FMDV
C3Arg/85 and its three clonal derivatives did not form
visible plaques on BHK-Rb cells but formed normal size plaques on
BHK-21 cell monolayers. The three subclones C3Rb-Ac14, -c15, and -c16 and the parental C3-RbA population (Fig. 1B)
showed identical phenotypes regarding virulence for modified and
parental BHK-21 cells and plaque morphology (Table
2).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Diagram of the origin of the cells and viruses used in
the present study. (A) Persistent infection of BHK-21 cells with
FMDV C-S8c1 (9). At passage 70, the persistently infected
culture was cured of FMDV by ribavirin treatment (8),
yielding the uncloned population BHK-Rb. At passage 74, many cell
clones free of FMDV were obtained by terminal dilution (11).
One clone that is highly resistant to FMDV is BHK-R74-A4. (B) The
C3Arg/85 used is a plaque-purified preparation derived from
the natural isolate C3Arg/85 (39, 43) as
described in Materials and Methods. Either this preparation (open
circles) or one of three plaque-purified subpopulations (-c1, -c2, or
-c3 [empty squares]) was used to infect BHK-Rb cells. Viruses
rescued from the supernatant of infected BHK-Rb cells at 8 or 10 days postinfection are designated C3-RbA (8 days
postinfection), -B, -C, -D, and -E (10 days postinfection) (filled
circles). The letters correspond to experiments A to E listed in Table
1. c14, c15, and c16 (filled squares) are clonal subpopulations
obtained by plating population C3-RbA onto a BHK-Rb
cell monolayer, isolating virus from three single plaques and then
passaging the virus twice in BHK-Rb cells. Further details about
experimental procedures are given in Materials and Methods.
|
|
Growth characteristics of FMDV C3Arg/85 and
C3-Rb in BHK-21, BHK-Rb, and BHK-R74-A4
cells.
The infection of BHK-21, BHK-Rb, and BHK-R74-A4
cells by C3Arg/85 and its C3-Rb derivatives was
studied by immunofluorescence and by a comparative analysis of virus
yields and levels of intracellular viral RNA. The limited
permissivity of BHK-Rb cells to FMDV C3Arg/85 was due
at least in part to the heterogeneity of cells with regard to
susceptibility to this virus, as indicated by immunofluorescence analysis. Clusters of brightly fluorescent BHK-Rb cells amounted to
only half of the cell population, even at 24 h postinfection (Fig.
2A and B). In contrast, in infections of
BHK-Rb cells with FMDV C3-Rb, viral antigens were
detected in the majority of cells at 5 h postinfection (Fig. 2C).
These results are in agreement with the higher yield of virus in
infections with the C3-Rb variants in comparison to that in
infections with the parental C3Arg/85 and with the
observation of complete killing of BHK-Rb cells at 10 h after
infection with C3-Rb variant FMDVs (Fig. 3B and
E).

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 2.
Indirect immunofluorescence analysis of BHK-Rb and
CHO cells infected with different FMDVs. Cells were infected at a
multiplicity of infection of 10 PFU/cell. After virus adsorption (1 h,
37°C) the cell monolayers were extensively washed with DMEM and
overlaid with DMEM-fetal calf serum (2% for BHK-Rb cells and 5%
for CHO cells). At the time postinfection indicated for each experiment
(panels A to I), the presence of FMDV antigens was revealed by
indirect immunofluorescence analysis performed as indicated in
Materials and Methods. (A to C) BHK-Rb cells were infected with
either FMDV C3Arg/85 for 5 h (A) or 24 h (B) or
FMDV C3-Rbc15 for 5 h (C). (D to G) Wild-type CHO
cells infected for 24 h with C3Arg/85 (D),
C3-Rbc15 (E), C3-RbB (F), and
C3-RbE (G). (H and I) Mutant CHO pgs D-677 (H) or CHO pgs
A-745 (I) infected for 24 h with C3-Rbc15. Results
indistinguishable from those shown with C3Arg/85 (panels A,
B, and D) were obtained with C3Arg/85c1, -c2, and -c3.
Likewise, results indistinguishable from those shown with
C3-Rbc15, C3-RbB, and C3-RbE
(panels E to I) were obtained with the other C3-Rb viruses
selected in BHK-Rb cells (data not shown). The origins of the cells
and the FMDVs are described in Materials and Methods, Fig. 1, and Table
1.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Determination of virus production (A to C) and
intracellular viral RNA (D to F) upon infection of BHK-21 and
modified BHK-21 cells with different FMDVs. BHK-21 cells (A and
D) or BHK-Rb cells (B and E) or BHK-R74-A4 cells (C and F) were
infected with C3Arg/85 ( ), C3-Rbc15 ( ),
or C3-Rbc16 ( ) at a multiplicity of infection of
10 PFU/cell. At the indicated times postinfection, samples from the
culture medium were withdrawn and titrated (panels A to C). The time at
which a complete cytopathic effect was observed is indicated by dotted
arrows (infections with C3-Rbc15 or C3-Rbc16)
or by a complete arrow (infection with C3Arg/85). For
other infections the cytopathic effect observed at the indicated
times postinfection was not complete (Table 2). The viral yields from
infections with other C3-Rb viruses were very similar
to those shown for C3-Rbc15 and -c16. In parallel
infections, total cellular RNA was extracted at the indicated times
(panels D to F). FMDV RNA was extracted and quantitated by dot blot
hybridization as described in Materials and Methods. In panels D to F,
numbers on the ordinate represent the accumulated amount of FMDV RNA
expressed as the percentage of the maximum value in each experiment.
Infections were with C3Arg/85 (empty columns),
C3-Rbc15 (columns with stripes), or C3-Rbc16
(filled columns). Procedures for infection with FMDV, titrations with
plaque assays, and quantification of FMDV RNA are detailed in Materials
and Methods.
|
|
The ability of C3-Rb viruses to overcome the BHK-Rb
cells' resistance to infection was further tested with BHK-R74-A4
cells, one of the stable cell clones isolated from an FMDV-C-S8c1
carrier culture that was very resistant to infection by FMDV C-S8c1
(11) (Fig. 1A). Single-step growth curves revealed that
while BHK-R74-A4 cells produce 100-fold-lower yields of FMDV
C3Arg/85 than the standard BHK-21 cells do, both cell
types yield similar amounts of C3-Rb virus (Fig. 3A and C).
The resistance of BHK-R74-A4 cells to C3Arg/85 and
their permissivity to C3-Rb viruses were confirmed by
comparing the levels of intracellular FMDV RNA in infections with
either virus (Fig. 3F). In addition, C3-Rb viruses, but not the parental C3Arg/85, were able to kill BHK-R74-A4
cells, although their virulence was lower for these cells than for
BHK-Rb or BHK-21 cells (Table 2).
In the parental, unmodified BHK-21 cells, both C3-Rb
viruses and the parental C3Arg/85 replicated equally well
as indicated by the equivalent amounts of virus yields and by the
levels of intracellular FMDV RNA at early times postinfection (Fig. 3A
and D). C3-Rb viruses, however, produced complete cell
killing at around 9 h postinfection, in contrast to the 16 to
20 h required in infections with C3Arg/85. It should
be noted that, in agreement with the latter observation,
C3-Rb viruses are 1,000-fold more virulent than the
parental C3Arg/85 for BHK-21 cells (Table 2). This
finding indicates that the hypervirulence for BHK-21 cells of FMDV
C3-Rb is related to factors other than an increase in virus production.
Replication of C3-Rb viruses in CHO cells.
CHO
cells under standard conditions cannot be infected by natural FMDV
isolates (2, 32, 41, 49). However, adaptation of FMDV to
cell culture often leads to populations that can infect CHO cells via
interaction with the surface glycosaminoglycan heparan sulfate (2,
32, 41, 49). Thus, it was of interest to determine whether
FMDV C3-Rb had acquired the ability to infect CHO
cells and to bind heparin. Infection of wild-type CHO cells with
C3Arg/85 or with its clonal derivatives -c1, -c2, and -c3 did not produce virus progeny (Table 3).
Furthermore, immunofluorescence assays indicated an absence of
detectable FMDV antigen in the cells, suggesting an early block in
infection (Fig. 2D). In contrast, C3-Rb viruses selected in
five independent experiments were able to replicate in wild-type CHO
cells as indicated by virus production and by immunofluorescence
analysis (Table 3 and Fig. 2E to G). Mutant CHO cells pgs D-677 and pgs
A-745, which are deficient in glycosaminoglycans (27, 35),
were negative for FMDV antigens by immunofluorescence assays (Fig. 2H
and I) and did not yield C3-Rb progeny (results not shown).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Replication in wild-type CHO cells and binding to
heparin-Sepharose of parental and variant FMDV
C3Arg/85 populations
|
|
Since infection of CHO cells by C3-Rb viruses required the
presence of cell surface heparan sulfate, the abilities of the different virus populations to bind heparin were analyzed. The results
(Table 3) show that all variants tested acquired the ability to
bind to heparin, although the extent of binding was lower than that
reported for FMDV C1 with a long history of passages in cell culture
(2).
Few genetic changes are associated with the phenotypic
modifications of C3-Rb viruses.
To define
the molecular basis of the phenotypic modifications undergone by FMDV
C3Arg/85 in its replication in BHK-Rb cells, the entire
genomic nucleotide sequence of the working stock of FMDV
C3Arg/85 and that of the virulent clone
C3-RbAc15 were determined and compared. Only two amino acid
substitutions were identified in the viral proteins as follows (Table
4): Asp-9
Ala in VP3 and Gly-110
Arg
in VP1. In addition, one silent mutation was identified at position
7624. To determine whether the two amino acid
substitutions were consistently found in selected C3Arg/85
variants, the genomic regions corresponding to amino
acids 9 of VP3 and 110 of VP1 were sequenced for FMDVs
C3-RbA, C3-RbAc16, C3-RbB,
C3-RbC, C3-RbD, and C3-RbE. All
C3-Rb viruses included an Asp-9
Ala substitution in
VP3 and either a His-108
Arg substitution or a Gly-110
Arg substitution in VP1. In particular, C3-RbC was a mixed
population containing both His and Arg at position 108 of VP1 and Gly
and Arg at position 110 of VP1, with only Ala at position 9 of VP3. C3-RbE included an Asp-9
Ala substitution in VP3 and only
a His-108
Arg substitution in VP1. The sequencing of the entire
P1-coding region of C3-RbE revealed no other mutations
(Table 4). An analysis of 22 molecular clones from population
C3-RbC showed that each clone included Arg at either
position 108 or position 110 in VP1. None of the clones obtained had
sequences with Arg in both positions 108 and 110 of VP1
(44). The size of the poly(C) tract was determined for
FMDV C3Arg/85c1, C3Arg/85c2,
C3Arg/85c3, C3-RbA,
C3-RbAc15, C3-RbAc16, C3-RbB,
C3-RbC, C3-RbD, and C3-RbE. No
significant variations were seen between the C3-Rb viruses
and the parental C3Arg/85; the length of the poly(C) tract
in all the genomes analyzed ranged from 204 to 214 C residues.
The three amino acid substitutions found in C3-Rb viruses
cluster at the virion fivefold axis (Fig.
4) and represent a net increase of
positive charges on the virion surface. We conclude that the same two
capsid replacements at position 9 of VP3 and at position 108 or
position 110 of VP1 were repeatedly selected during infection of
BHK-Rb cells by populations of FMDV C3Arg/85 and that
these substitutions were associated with the phenotypic modifications
of C3-Rb viruses.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 4.
Location in the three-dimensional structure of FMDV of
serotype C (34) of the amino acids replaced in the
C3-Rb FMDVs (Asp-9 Ala in VP3 and His-108 Arg in VP1 or
Gly-110 Arg in VP1). (A) Stereodiagram of a crystallographic protomer
of C-S8c1 in which the three amino acid substitutions are modeled. The
capsid proteins VP1, VP2, and VP3 are depicted as grey, white/stippled,
and black ribbons, respectively. The substituted residues are shown as
spheres and indicated by the single-letter amino acid code (A = Ala; R = Arg). (B) Diagram of the pentamer subunit showing
substitutions Asp-9 Ala in VP3 and His-108 Arg in VP1. (C) Pentamer
with substitutions Asp-9 Ala in VP3 and Gly-110 Arg in VP1. A
reference protomer (lower part of the structure) is depicted as in
panel A. The cluster of positive charges around the fivefold axis is
apparent in both cases. The procedures used to model the amino acid
substitutions are described in Materials and Methods. The structures
were drawn by using a modified version of MOLSCRIPT (33).
|
|
 |
DISCUSSION |
The modified BHK-Rb cells were selected during the course of a
persistent infection of cloned BHK-21 cells with FMDV clone C-S8c1
(9, 11, 12). The system selects for variant cells which are
partially resistant to the virus and for viruses which are
hypervirulent for the cells. This coevolution favors the survival of
both the host cells and the resident virus (11, 12, 37). Coevolution of cells and viruses has been described for a number of
other viral systems (1, 4-6, 40, 45, 46) and thus cannot be
regarded as a rare phenomenon. BHK-Rb cell populations are
heterogeneous in that they are composed of cell types that differ in
degree of cellular transformation and of resistance to infection by
FMDV (11, 12). Upon infection of this heterogeneous cell
population with FMDV C3Arg/85, an initial round of partial cell lysis took place on the second to third day postinfection. The
more-resistant cells persisted for several additional days, supporting
viral replication, as suggested by their continuing viability and the
shedding of virus into the culture medium. The cell-to-cell variation
in FMDV susceptibility within the BHK-Rb cell population was
previously documented by cell cloning and phenotypic testing
(11). The cellular heterogeneity has been confirmed and
extended in the present study by indirect immunofluorescence analysis
of infections with C3Arg/85 (Fig. 2). The negative
immunofluorescence of about 50% of the BHK-Rb cells upon infection
with C3Arg/85 suggests a block in an early step of the
infectious cycle of FMDV in this cell subpopulation (receptor
recognition, entry, uncoating, or early protein or RNA synthesis). In
the more-resistant BHK-Rb cell subpopulations, variant viruses
depicting minimal genetic changes but increased virulence for their
host cells were selected. The same amino acid substitutions were
selected in independent infections by clonal C3Arg/85
preparations, and therefore were the result of independent mutational
events (Fig. 1B and Table 4).
The adaptation of RNA viruses is based on the continuous generation of
mutant genomes, resulting in extremely heterogeneous and dynamic mutant
swarms, termed viral quasispecies (14, 17, 18, 23, 24, 30).
Average mutation rates for a number of RNA viruses have been
estimated at 10
3 to 10
5 substitutions
per nucleotide and round of copying (reviewed in references
17 and 22). Thus, for an RNA
genome of about 8 kb, such as FMDV, with a mutation rate of
10
4 substitutions per nucleotide copied, every progeny
RNA molecule produced during a replication process might contain an
average of about one mutation. The number of mutations per genome could theoretically follow a Poisson distribution assuming that the occurrence of mutations along the genome is random and assuming their
neutral character (15, 20). Obviously, mutations may not
occur at random, and many of them will be deleterious and therefore
eliminated by negative, or purifying, selection (17). The
evolution of a viral quasispecies will be influenced not only by
mutational input but also by the number of rounds of genome copying and
by the population size of the replicating genomes (17, 20, 23, 24,
30). The quasispecies structure and dynamics predict that
variants with one mutation or a few mutations will be common in mutant
distributions and thus will be selected whenever they give the virus a
selective advantage in the environment at hand (14). This
scenario provides a plausible interpretation for the observations
described in the present study. Furthermore, repetitive, or
deterministic, to use a more fundamental term, selection of the same
variants will occur when a limited number of molecular solutions are
available to a virus for coping with a selective constraint (17,
19). Had the molecular solutions of C3Arg/85 required
a constellation of mutations beyond the reach of the sequence space
(23, 24) being explored by the virus to replicate in
BHK-Rb cells, adaptation would not have been feasible and the
selection of C3-Rb variants would not have occurred. We have previously suggested that functional and structural constraints are probably the main limitations of the evolution of RNA viruses given
their high mutation potential (17, 19).
In capsids with icosahedral symmetry, surface residues tend to be more
tolerant to replacements than internal capsid residues engaged in
interactions with other amino acids (34). The residues at
the surface are those that are the most frequently replaced in the
course of large population passages of FMDV (26). The two
amino acid substitutions found in all the C3-Rb populations analyzed (Asp-9
Ala in VP3 and His-108
Arg or Gly-110
Arg in VP1) cluster at the fivefold axis of the FMDV particle (Fig. 4). This is the
site at which the persistent FMDV R100 (13) also includes a
cluster of amino acid substitutions, e.g., Asp-9
Ala in VP3. It is
interesting that both R100 and the C3-Rb viruses described here have high virulence for BHK-21 cells and a small-plaque
morphology (13). Remarkably, the two amino acid
substitutions in the capsid of C3Arg/85, without any other
substitution in any viral protein, conferred to the C3-Rb
viruses an increased virulence for BHK-21 cells, the ability
to infect modified BHK-21 cells, a small-plaque morphology,
and the potential to bind heparin and infect wild-type CHO cells. This
latter change represents a modification of cell tropism that has been
documented with a number of different FDMV isolates (2, 32, 41,
49). Jackson et al. (32) showed that binding to
cellular heparan sulfate was required by FMDV of serotype O for the
efficient infection of cells in culture. Sa-Carvalho et al.
(49) documented that heparin binding and cell culture
adaptation of FMDV O1 Campos entailed the acquisition of
positively charged residues at VP2 residue 134 and VP3 residue 56. In
an FMDV of serotype C1 which was subjected to 213 serial cytolytic passages in BHK-21 cells (MARLS virus
[2]), two amino acid substitutions (Lys-173
Met in
VP3 and Ser-144
Leu in VP1) were associated with the loss of the
ability of the virus to bind heparin and infect CHO cells
(2). These substitutions affect a capsid region around the
G-H loop of VP1, away from the fivefold axis (34).
Comparison of results with MARLS and the C3-Rb viruses reinforces the view that the FMDV capsid is an important
determinant of virulence for BHK-21 cells (2) and that
increased affinity for heparin and alterations in cell tropism may be
mediated by a number of independent sites on the viral
capsid (2). The systematic selection of the same types of
variant C3Arg/85 in BHK-Rb cells shows that when
selective forces are strong and the genetic modifications needed to
respond to a selective constraint are attainable within the sequence
space available to the virus (23, 24), phenotypic shifts can
be reproducible and rapid (31).
The repeated selection of two capsid mutations was also observed during
persistent infections of poliovirus in primary cultures of human fetal
brain cells (42). de la Torre et al. (10) found that transfection of HeLa cells with independent clones of a
temperature-sensitive poliovirus mutant resulted not only in the
expected transition that eliminated temperature sensitivity but also in
four additional silent substitutions that precisely reverted the mutant
sequence to that of the wild-type poliovirus. The results with FMDV
prove that the replication of viruses in partially permissive cells may
promote the selection of genetic and phenotypic variants, including
viral mutants with an altered host range. This selection need not be
the result of a prolonged persistent infection but can occur during the
short-term survival of a virus with a partially permissive host cell.
The results of the present study illustrate the impressive adaptive
potential of viral quasispecies.
 |
ACKNOWLEDGMENTS |
We are indebted to M. Dávila for expert technical
assistance and to José Pizarro for help with sequencing experiments.
Work in Madrid was supported by grant PM97-0060-C02 from DEGS,
grant PSS0885 from the EU, and the Fundación Ramón Areces. Work in Buenos Aires was supported by CONICET and INTA. M.T.F.-F. thanks Laboratorios BAGO (Buenos Aires, Argentina) for support. Visits to Madrid and Buenos Aires were funded by a CSIC-CONICET cooperative grant. M.T.F.-F.'s sabbatical leave in Madrid was funded
by MEC (Spain).
 |
FOOTNOTES |
*
Corresponding author. Mailing address for Esteban
Domingo: Centro de Biología Molecular "Severo Ochoa,"
Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid,
Spain. Phone: 34-91-3978485. Fax: 34-91-3974799. E-mail:
edomingo{at}cbm.uam.es. Mailing address for Maria T. Franze-Fernández: Centro de Virología Animal, Serrano 669, 1414 Buenos Aires, Argentina. Phone and fax: 54-1-825-1863. E-mail: MTFF{at}cevan.sld.ar.
 |
REFERENCES |
| 1.
|
Ahmed, R.,
W. M. Canning,
R. S. Kauffman,
A. H. Sharpe,
J. V. Hallum, and B. N. Fields.
1981.
Role of the host cell in persistent viral infection: coevolution of L cells and reovirus during persistent infection.
Cell
25:325-332[Medline].
|
| 2.
|
Baranowski, E.,
N. Sevilla,
N. Verdaguer,
C. M. Ruiz-Jarabo,
E. Beck, and E. Domingo.
1998.
Multiple virulence determinants of foot-and-mouth disease virus in cell culture.
J. Virol.
72:6362-6372[Abstract/Free Full Text].
|
| 3.
|
Burrows, R.
1966.
Studies on the carrier state of cattle exposed to foot-and-mouth disease virus.
J. Hyg.
64:81-90.
|
| 4.
|
Calvez, V.,
I. Pelletier,
T. Couderc,
N. Pavio-Guédo,
B. Blondel, and F. Colbère-Garapin.
1995.
Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
Virology
212:309-322[Medline].
|
| 5.
|
Charini, A.,
S. Arista,
A. Giammanco, and A. Sinatra.
1983.
Rotavirus persistence in cell cultures: selection of resistant cells in the presence of fetal calf serum.
J. Gen. Virol.
64:1101-1110[Abstract/Free Full Text].
|
| 6.
|
Chen, W., and R. S. Baric.
1996.
Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence.
J. Virol.
70:3947-3960[Abstract].
|
| 7.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 8.
|
de la Torre, J. C.,
B. Alarcón,
E. Martínez-Salas,
L. Carrasco, and E. Domingo.
1987.
Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus.
J. Virol.
61:233-235[Abstract/Free Full Text].
|
| 9.
|
de la Torre, J. C.,
M. Dávila,
F. Sobrino,
J. Ortín, and E. Domingo.
1985.
Establishment of cell lines persistently infected with foot-and-mouth disease virus.
Virology
145:24-35[Medline].
|
| 10.
|
de la Torre, J. C.,
C. Giachetti,
B. L. Semler, and J. J. Holland.
1992.
High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus.
Proc. Natl. Acad. Sci. USA
89:2531-2535[Abstract/Free Full Text].
|
| 11.
|
de la Torre, J. C.,
E. Martínez-Salas,
J. Díez, and E. Domingo.
1989.
Extensive cell heterogeneity during a persistent infection with foot-and-mouth disease virus.
J. Virol.
63:59-63[Abstract/Free Full Text].
|
| 12.
|
de la Torre, J. C.,
E. Martínez-Salas,
J. Díez,
A. Villaverde,
F. Gebauer,
E. Rocha,
M. Dávila, and E. Domingo.
1988.
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture.
J. Virol.
62:2050-2058[Abstract/Free Full Text].
|
| 13.
|
Díez, J.,
M. Dávila,
C. Escarmís,
M. G. Mateu,
J. Domínguez,
J. J. Pérez,
E. Giralt,
J. A. Melero, and E. Domingo.
1990.
Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture.
J. Virol.
64:5519-5528[Abstract/Free Full Text].
|
| 14.
|
Domingo, E.
1996.
Biological significance of viral quasispecies.
Viral Hepatitis Rev.
2:247-261.
|
| 15.
|
Domingo, E.
1997.
RNA virus evolution, population dynamics, and nutritional status.
Biol. Trace Elem. Res.
56:23-30[Medline].
|
| 16.
|
Domingo, E.,
M. Dávila, and J. Ortín.
1980.
Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus.
Gene
11:333-346[Medline].
|
| 17.
|
Domingo, E., and J. J. Holland.
1994.
Mutation rates and rapid evolution of RNA viruses, p. 161-184.
In
S. S. Morse (ed.), Evolutionary biology of viruses. Raven Press, New York, N.Y.
|
| 18.
|
Domingo, E.,
J. J. Holland,
C. Biebricher, and M. Eigen.
1995.
Quasispecies: the concept and the word, p. 171-180.
In
A. Gibbs, C. Calisher, and F. García-Arenal (ed.), Molecular basis of virus evolution. Cambridge University Press, Cambridge, United Kingdom.
|
| 19.
|
Domingo, E.,
M. G. Mateu,
C. Escarmís,
E. Martínez-Salas,
D. Andreu,
E. Giralt,
N. Verdaguer, and I. Fita.
1996.
Molecular evolution of aphthoviruses.
Virus Genes
11:197-207.
|
| 20.
|
Domingo, E.,
D. L. Sabo,
T. Taniguchi, and C. Weissmann.
1978.
Nucleotide sequence heterogeneity of an RNA phage population.
Cell
13:735-744[Medline].
|
| 21.
|
Donn, A.,
M. Castagnaro, and A. I. Donaldson.
1995.
Ultrastructural and replicative features of foot-and-mouth disease virus in persistently infected BHK-21 cells.
Arch. Virol.
140:13-25[Medline].
|
| 22.
|
Drake, J. W.
1993.
Rates of spontaneous mutations among RNA viruses.
Proc. Natl. Acad. Sci. USA
90:4171-4175[Abstract/Free Full Text].
|
| 23.
|
Eigen, M.
1992.
Steps towards life.
Oxford University Press, Oxford, United Kingdom.
|
| 24.
|
Eigen, M., and C. Biebricher.
1988.
Sequence space and quasispecies distribution, p. 211-245.
In
E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA genetics. CRC Press, Inc., Boca Raton, Fla.
|
| 25.
|
Escarmís, C.,
M. Toja,
M. Medina, and E. Domingo.
1992.
Modifications of the 5' untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture.
Virus Res.
26:113-125[Medline].
|
| 26.
|
Escarmís, C.,
M. Dávila,
N. Charpentier,
A. Bracho,
A. Moya, and E. Domingo.
1996.
Genetic lesions associated with Muller's ratchet in an RNA virus.
J. Mol. Biol.
264:255-267[Medline].
|
| 27.
|
Esko, J. D.,
T. E. Stewart, and W. H. Taylor.
1985.
Animal cell mutants defective in glycosaminoglycans biosynthesis.
Proc. Natl. Acad. Sci. USA
82:3197-3201[Abstract/Free Full Text].
|
| 28.
|
Ferrer, M.,
A. Hémar,
V. Duprez,
R. Hellio, and A. Dantry-Varsat.
1993.
Both the and chains of high affinity interleukin 2 receptors are located in intracellular vesicles when their ligand is endocytosed.
Eur. J. Cell Biol.
60:276-282[Medline].
|
| 29.
|
Gebauer, F.,
J. C. de la Torre,
I. Gomes,
M. G. Mateu,
H. Barahona,
B. Tiraboschi,
I. Bergmann,
M. G. Augé de Mello, and E. Domingo.
1988.
Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle.
J. Virol.
62:2041-2049[Abstract/Free Full Text].
|
| 30.
|
Holland, J. J.,
J. C. de la Torre, and D. A. Steinhauer.
1992.
RNA viral populations as quasispecies.
Curr. Top. Microbiol. Immunol.
176:1-20[Medline].
|
| 31.
|
Holland, J. J.,
K. Spindler,
F. Horodyski,
E. Grabau,
S. Nichol, and S. Van dePol.
1982.
Rapid evolution of RNA genomes.
Science
215:1577-1585[Abstract/Free Full Text].
|
| 32.
|
Jackson, T.,
F. M. Ellard,
R. Abu Ghazaleh,
S. M. Brookes,
W. E. Blakemore,
A. H. Corteyn,
D. I. Stuart,
J. W. I. Newman, and A. M. Q. King.
1996.
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.
J. Virol.
70:5282-5287[Abstract/Free Full Text].
|
| 33.
|
Kraulis, P. F.
1991.
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures.
J. Appl. Crystallogr.
24:946-950.
|
| 34.
|
Lea, S.,
J. Hernández,
W. Blakemore,
E. Brocchi,
S. Curry,
E. Domingo,
E. Fry,
R. A. Ghazaleh,
A. King,
J. Newman,
D. Stuart, and M. G. Mateu.
1994.
The structure and antigenicity of a type C foot-and-mouth disease virus.
Structure
2:123-139[Medline].
|
| 35.
|
Lidholt, K.,
J. L. Weinke,
C. S. Kiser,
F. N. Lugemwa,
K. J. Bame,
S. Cheifetz,
J. Massagué,
U. Lindahl, and J. D. Esko.
1992.
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a chinese hamster ovary cell mutant defective in heparin sulfate biosynthesis.
Proc. Natl. Acad. Sci. USA
89:2267-2271[Abstract/Free Full Text].
|
| 36.
|
Marilat, V.,
P. Augé de Mello,
B. Tiraboschi,
E. Beck,
I. Gomes, and I. E. Bergmann.
1994.
Genetic variation of foot-and-mouth disease virus during persistent infection in cattle.
Virus Res.
34:31-48[Medline].
|
| 37.
|
Martín Hernández, A. M.,
E. C. Carrillo,
N. Sevilla, and E. Domingo.
1994.
Rapid cell variation can determine the establishment of a persistent viral infection.
Proc. Natl. Acad. Sci. USA
91:3705-3709[Abstract/Free Full Text].
|
| 38.
|
Mateu, M. G.,
J. L. Da Silva,
E. Rocha,
D. L. De Brum,
A. Alonso,
L. Enjuanes,
E. Domingo, and H. Barahona.
1988.
Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C.
Virology
166:113-124[Medline].
|
| 39.
|
Mateu, M. G.,
J. Hernández,
M. A. Martínez,
D. Feigelstock,
S. Lea,
J. J. Pérez,
E. Giralt,
D. Stuart,
E. L. Palma, and E. Domingo.
1994.
Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
J. Virol.
68:1407-1417[Abstract/Free Full Text].
|
| 40.
|
Mrukowicz, J. Z.,
J. D. Wetzel,
M. I. Goral,
A. B. Fogo,
P. F. Wright, and T. S. Dermody.
1998.
Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells.
J. Virol.
72:3088-3097[Abstract/Free Full Text].
|
| 41.
|
Neff, S.,
D. Sa-Carvalho,
E. Rieder,
P. Mason,
S. D. Blystone,
E. J. Brown, and B. Baxt.
1998.
Foot-and-mouth disease virus virulent for cattle utilizes the integrin v 3 as its receptor.
J. Virol.
72:3587-3594[Abstract/Free Full Text].
|
| 42.
|
Pavio, N.,
M.-H. Buc-Caron, and F. Colbère-Garapin.
1996.
Persistent poliovirus infection of human fetal brain cells.
J. Virol.
70:6395-6401[Abstract].
|
| 43.
|
Piccone, M. E.,
G. Kaplan,
L. Giavedoni,
E. Domingo, and E. L. Palma.
1988.
VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences.
J. Virol.
62:1469-1473[Abstract/Free Full Text].
|
| 44.
| Rocha, C., and C. Escarmís. 1998. Unpublished results.
|
| 45.
|
Ron, D., and J. Tal.
1985.
Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L cells.
J. Virol.
55:424-430[Abstract/Free Full Text].
|
| 46.
|
Ron, D., and J. Tal.
1986.
Spontaneous curing of a minute virus of mice carrier state by selection of cells with an intracellular block of viral replication.
J. Virol.
58:26-30[Abstract/Free Full Text].
|
| 47.
|
Roussel, A., and C. Cambillau.
1989.
TURBO-FRODO, p. 77-78.
In
Silicon Graphics geometry partners directory. Silicon Graphics, Mountain View, Calif.
|
| 48.
|
Rueckert, R. R.
1996.
Picornaviridae: the viruses and their replication, p. 609-654.
In
B. N. Fields, et al. (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 49.
|
Sa-Carvalho, D.,
E. Rieder,
B. Baxt,
R. Rodarte,
A. Tanuri, and P. Mason.
1997.
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.
J. Virol.
71:5115-5123[Abstract].
|
| 50.
|
Salt, J. S.
1993.
The carrier state in foot-and-mouth disease an immunological review.
Br. Vet. J.
149:207-223[Medline].
|
| 51.
|
Sevilla, N., and E. Domingo.
1996.
Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification.
J. Virol.
70:6617-6624[Abstract/Free Full Text].
|
| 52.
|
Sobrino, F.,
M. Dávila,
J. Ortín, and E. Domingo.
1983.
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture.
Virology
128:310-318[Medline].
|
| 53.
|
Sutmoller, P.,
J. W. McVicar, and G. E. Cottral.
1968.
The epizootical importance of foot-and-mouth disease carriers. I. Experimentally produced foot-and-mouth disease carriers in susceptible and immune cattle.
Arch. Gesamte Virusforsch.
23:227-235[Medline].
|
| 54.
|
Taboga, O.,
C. Tami,
E. Carrillo,
J. I. Núñez,
A. Rodríguez,
J. C. Saiz,
E. Blanco,
M.-L. Valero,
X. Roig,
J. A. Camarero,
D. Andreu,
M. G. Mateu,
E. Giralt,
E. Domingo,
F. Sobrino, and E. L. Palma.
1997.
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
J. Virol.
71:2606-2614[Abstract].
|
| 55.
|
van Bekkum, J. G.,
H. S. Frenkel,
H. H. J. Frederiks, and S. Frenkel.
1959.
Observations on the carrier state of cattle exposed to foot-and-mouth disease virus.
Tijdschr. Diergeneeskd.
84:1159-1164.
|
| 56.
|
Woodbury, E. L.
1995.
A review of the possible mechanisms for the persistence of foot-and-mouth disease virus.
Epidemiol. Infect.
114:1-13[Medline].
|
Journal of Virology, December 1998, p. 10171-10179, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Herrera, M., Grande-Perez, A., Perales, C., Domingo, E.
(2008). Persistence of foot-and-mouth disease virus in cell culture revisited: implications for contingency in evolution. J. Gen. Virol.
89: 232-244
[Abstract]
[Full Text]
-
Carrillo, C., Lu, Z., Borca, M. V., Vagnozzi, A., Kutish, G. F., Rock, D. L.
(2007). Genetic and Phenotypic Variation of Foot-and-Mouth Disease Virus during Serial Passages in a Natural Host. J. Virol.
81: 11341-11351
[Abstract]
[Full Text]
-
Mateo, R., Mateu, M. G.
(2007). Deterministic, Compensatory Mutational Events in the Capsid of Foot-and-Mouth Disease Virus in Response to the Introduction of Mutations Found in Viruses from Persistent Infections. J. Virol.
81: 1879-1887
[Abstract]
[Full Text]
-
Misinzo, G., Delputte, P. L., Meerts, P., Lefebvre, D. J., Nauwynck, H. J.
(2006). Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells.. J. Virol.
80: 3487-3494
[Abstract]
[Full Text]
-
Monaghan, P., Gold, S., Simpson, J., Zhang, Z., Weinreb, P. H., Violette, S. M., Alexandersen, S., Jackson, T.
(2005). The {alpha}v{beta}6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J. Gen. Virol.
86: 2769-2780
[Abstract]
[Full Text]
-
Cuevas, J. M., Moya, A., Sanjuan, R.
(2005). Following the very initial growth of biological RNA viral clones. J. Gen. Virol.
86: 435-443
[Abstract]
[Full Text]
-
Williams, C. H., Kajander, T., Hyypia, T., Jackson, T., Sheppard, D., Stanway, G.
(2004). Integrin {alpha}v{beta}6 Is an RGD-Dependent Receptor for Coxsackievirus A9. J. Virol.
78: 6967-6973
[Abstract]
[Full Text]
-
Jackson, T., Clark, S., Berryman, S., Burman, A., Cambier, S., Mu, D., Nishimura, S., King, A. M. Q.
(2004). Integrin {alpha}v{beta}8 Functions as a Receptor for Foot-and-Mouth Disease Virus: Role of the {beta}-Chain Cytodomain in Integrin-Mediated Infection. J. Virol.
78: 4533-4540
[Abstract]
[Full Text]
-
Zhao, Q., Pacheco, J. M., Mason, P. W.
(2003). Evaluation of Genetically Engineered Derivatives of a Chinese Strain of Foot-and-Mouth Disease Virus Reveals a Novel Cell-Binding Site Which Functions in Cell Culture and in Animals. J. Virol.
77: 3269-3280
[Abstract]
[Full Text]
-
Boonyakiat, Y., Hughes, P. J., Ghazi, F., Stanway, G.
(2001). Arginine-Glycine-Aspartic Acid Motif Is Critical for Human Parechovirus 1 Entry. J. Virol.
75: 10000-10004
[Abstract]
[Full Text]
-
Mandl, C. W., Kroschewski, H., Allison, S. L., Kofler, R., Holzmann, H., Meixner, T., Heinz, F. X.
(2001). Adaptation of Tick-Borne Encephalitis Virus to BHK-21 Cells Results in the Formation of Multiple Heparan Sulfate Binding Sites in the Envelope Protein and Attenuation In Vivo. J. Virol.
75: 5627-5637
[Abstract]
[Full Text]
-
Knowles, N. J., Davies, P. R., Henry, T., O'Donnell, V., Pacheco, J. M., Mason, P. W.
(2001). Emergence in Asia of Foot-and-Mouth Disease Viruses with Altered Host Range: Characterization of Alterations in the 3A Protein. J. Virol.
75: 1551-1556
[Abstract]
[Full Text]
-
Fares, M. A., Moya, A., Escarmis, C., Baranowski, E., Domingo, E., Barrio, E.
(2001). Evidence for Positive Selection in the Capsid Protein-Coding Region of the Foot-and-Mouth Disease Virus (FMDV) Subjected to Experimental Passage Regimens. Mol Biol Evol
18: 10-21
[Abstract]
[Full Text]
-
Baranowski, E., Ruiz-Jarabo, C. M., Sevilla, N., Andreu, D., Beck, E., Domingo, E.
(2000). Cell Recognition by Foot-and-Mouth Disease Virus That Lacks the RGD Integrin-Binding Motif: Flexibility in Aphthovirus Receptor Usage. J. Virol.
74: 1641-1647
[Abstract]
[Full Text]
-
Beard, C. W., Mason, P. W.
(2000). Genetic Determinants of Altered Virulence of Taiwanese Foot-and-Mouth Disease Virus. J. Virol.
74: 987-991
[Abstract]
[Full Text]
-
Ruiz-Jarabo, C. M., Sevilla, N., Dávila, M., Gómez-Mariano, G., Baranowski, E., Domingo, E.
(1999). Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif. J. Gen. Virol.
80: 1899-1909
[Abstract]
[Full Text]